Cardiometabolic Response to a Sodium-bicarbonated Mineral Water
NCT ID: NCT02480816
Last Updated: 2018-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2015-05-01
2016-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Soybean Oil Trial of cArdiovascular Risk
NCT02404207
The Impact of Almond Nut Consumption on Markers of CVD & Metabolic Health
NCT02907684
Differential Effects of Lipids on Cardiovascular Diseases: A CALIBER Study
NCT01687686
Effects of Almonds on Cardiovascular Risk Factors
NCT01101230
Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators
NCT01610661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bicarbonated mineral water (BW)
Bicarbonated mineral water
Mineral water
Intake of 1 L per day of the mineral water (BW or CW) with main meals, crossover design
Control mineral water (CW)
Mineral water low in mineral content (control)
Mineral water
Intake of 1 L per day of the mineral water (BW or CW) with main meals, crossover design
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mineral water
Intake of 1 L per day of the mineral water (BW or CW) with main meals, crossover design
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Total-cholesterol \> 200 mg/dL and \< 300 mg/dL
Exclusion Criteria
* Total-cholesterol ≥300 mg/dL
* Triglycerides \> 250 mg/dL
* Total-cholesterol / HDL-cholesterol \> 6
* Being a usual consumer of carbonic mineral water
* BMI \< 20 and \>30 kg/m2
* Diabetes
* Hypertension or digestive, liver or renal disease
* Eating disorders
* Being under medication that could affect lipid metabolism
* Consumption of functional foods that could affect lipid metabolism (food containing n-3 fatty acids or phytosterols)
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Council, Spain
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
M Pilar Vaquero
Scientific researcher
References
Explore related publications, articles, or registry entries linked to this study.
Toxqui L, Vaquero MP. An Intervention with Mineral Water Decreases Cardiometabolic Risk Biomarkers. A Crossover, Randomised, Controlled Trial with Two Mineral Waters in Moderately Hypercholesterolaemic Adults. Nutrients. 2016 Jun 28;8(7):400. doi: 10.3390/nu8070400.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BW-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.